Zevra Therapeutics’ $91 Million Acquisition of Acer Therapeutics

Pietro Martinoia
Tagged:

Bryan Cave is advising Zevra, and Pillsbury is advising Acer Therapeutics.Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) and Acer Therapeutics Inc. (Nasdaq: ACER) announced the companies have entered into a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here